Elon Musk Promotes Weight-Loss Drug Mounjaro in Viral 'Ozempic Santa' Post

The billionaire’s endorsement of GLP-1 medications highlights a public divide with RFK Jr. over obesity solutions in the U.S.

Elon Musk revealed he uses the weight-loss drug Mounjaro in a Christmas post on X, dubbing himself 'Ozempic Santa' despite clarifying he is not using Ozempic itself.
Musk prefers Mounjaro over Ozempic, citing fewer side effects and greater effectiveness, after experiencing issues with high doses of Ozempic.
The post reignited debate over obesity treatments, with Musk advocating for affordable access to GLP-1 drugs, while RFK Jr., Trump’s Health and Human Services pick, emphasizes dietary changes as a solution.
GLP-1 inhibitors like Mounjaro and Ozempic, originally developed for diabetes management, have gained popularity for their weight-loss benefits but remain costly and inaccessible for many.
Musk, set to co-lead Trump’s Department of Government Efficiency, has been a vocal supporter of making these drugs widely available to combat obesity in the U.S.